Health & Biotech
Stories by Tim Boreham
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Dr Boreham’s Crucible: Can this cancer drug developer hit right notes for commercial success?
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Experts
CRITERION: Share valuations look overheated, but it’s a tale of two sectors
Health & Biotech
Health Check: PharmX has 99pc share of pharmacy market but reckons it has prescription for growth
Health & Biotech
Health Check: Hold the front page for a rush of clinical trial updates
Health & Biotech
Biocurious: Invion taps the power of light to zap solid tumours
Health & Biotech
Health Check: Nothing to spook investors in CSL’s update as the blood still flows thick
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
Health & Biotech
Dr Boreham’s Crucible: Can this nuclear medicine play’s tech explode in the US?
Experts